Co-administration of iloprost and eptifibatide in septic shock (CO-ILEPSS) —a randomised, controlled, double-blind investigator-initiated trial investigating safety and efficacy

Part of the pathophysiology in septic shock is a progressive activation of the endothelium and platelets leading to widespread microvascular injury with capillary leakage, microthrombi and consumption coagulop...

Source: Critical Care - September 5, 2019 Category: Intensive Care Authors: Rasmus Ehrenfried Berthelsen, Sisse Rye Ostrowski, Morten Heiberg Bestle and Per Ingemar Johansson Tags: Research Source Type: research